Nieborowska-Skorska M - Search Results

1

Eradication of LIG4-deficient glioblastoma cells by the combination of PARP inhibitor and alkylating agent.

Toma M, Witusik-Perkowska M, Szwed M, Stawski R, Szemraj J, Drzewiecka M, Nieborowska-Skorska M, Radek M, Kolasa P, Matlawska-Wasowska K, Sliwinski T, Skorski T. Toma M, et al. Among authors: nieborowska skorska m. Oncotarget. 2018 Dec 7;9(96):36867-36877. doi: 10.18632/oncotarget.26409. eCollection 2018 Dec 7. Oncotarget. 2018. PMID: 30627327 Free PMC article.

2

A model of Ph' positive chronic myeloid leukemia-blast crisis cell line growth in immunodeficient SCID mice.

Skórski T, Nieborowska-Skórska M, Calabretta B. Skórski T, et al. Folia Histochem Cytobiol. 1992;30(3):91-6. Folia Histochem Cytobiol. 1992. PMID: 1286728

3

[Use of autologous bone marrow transplants in the treatment of neoplasms].

Nieborowska-Skórska M, Skórski T. Nieborowska-Skórska M, et al. Wiad Lek. 1988 Mar 15;41(6):383-9. Wiad Lek. 1988. PMID: 3066014 Review. Polish. No abstract available.

4

Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells.

Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak MZ, Wen SC, Zon G, Gewirtz AM, Perussia B, Calabretta B. Skorski T, et al. Blood. 1995 Jul 15;86(2):726-36. Blood. 1995. PMID: 7606002 Free article.

5

The role of c-Myc protooncogene in chronic myelogenous leukemia.

Nieborowska-Skórska M, Ratajczak MZ, Calabretta B, Skórski T. Nieborowska-Skórska M, et al. Folia Histochem Cytobiol. 1994;32(4):231-4. Folia Histochem Cytobiol. 1994. PMID: 7758616

6

Oncogene-targeted antisense oligodeoxynucleotides combined with chemotherapy or immunotherapy: a new approach for tumor treatment?

Nieborowska-Skórska M, Nakashima M, Ratajczak M, Steplewski Z, Calabretta B, Skórski T. Nieborowska-Skórska M, et al. Folia Histochem Cytobiol. 1994;32(1):35-40. doi: 10.1007/BF02693351. Folia Histochem Cytobiol. 1994. PMID: 8026602

7

Successful mafosfamide purging of bone marrow from chronic myelogenous leukemia (CML) cells.

Nieborowska-Skórska M, Skórski T, Ratajczak MZ, Szczylik C, Malaguarnera L, Calabretta B. Nieborowska-Skórska M, et al. Folia Histochem Cytobiol. 1993;31(4):161-7. Folia Histochem Cytobiol. 1993. PMID: 8137996

8

Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide.

Skorski T, Nieborowska-Skorska M, Nicolaides NC, Szczylik C, Iversen P, Iozzo RV, Zon G, Calabretta B. Skorski T, et al. Proc Natl Acad Sci U S A. 1994 May 10;91(10):4504-8. doi: 10.1073/pnas.91.10.4504. Proc Natl Acad Sci U S A. 1994. PMID: 8183938 Free PMC article.

9

Highly efficient elimination of Philadelphia leukemic cells by exposure to bcr/abl antisense oligodeoxynucleotides combined with mafosfamide.

Skorski T, Nieborowska-Skorska M, Barletta C, Malaguarnera L, Szcyzlik C, Chen ST, Lange B, Calabretta B. Skorski T, et al. J Clin Invest. 1993 Jul;92(1):194-202. doi: 10.1172/JCI116549. J Clin Invest. 1993. PMID: 8325984 Free PMC article.

10

The diverse effect of topoisomerase I specific inhibitor (camptothecin) on normal and BCR/ABL-dependent hematopoietic cells proliferation: therapeutic implications.

Fertała J, Nieborowska-Skórska M, Calabretta B, Skórski T. Fertała J, et al. Folia Histochem Cytobiol. 1995;33(3):187-92. Folia Histochem Cytobiol. 1995. PMID: 8612872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters